A new collaboration between American Well and Boston-based Joslin Diabetes Center will explore telemedicine best practices for treating diabetes, the companies announced March 7.
Diabetes affects nearly 400 million people globally, but Joslin hopes that with telehealth, patients will be able to better manage the disease and its complications. Afterall, diabetes is a disease that requires close patient monitoring, medication adherence and lifestyle and behavioral changes, all of which can be managed via telehealth.
Joslin will use American Well's telehealth platform to match its diabetes specialists to patients who need care — some of whom travel from around the world to visit Joslin's facility in Boston. The new offering will let patients be seen more frequently, timely and conveniently.
"This speaks to the core of our connected care mission, leveraging technology to better treat and manage the full spectrum of care, particularly for prevalent chronic diseases like diabetes," said Ido Schoenberg, MD, chairman and CEO of American Well. "We continue to invest heavily in developing our best-in-class clinical telehealth platform and forging strategic partnerships with leading healthcare institutions like Joslin, because we see such great global potential in connecting providers with their patients wherever and whenever they need care."
More articles on health IT:
Philips adds IoT, cloud, AI to product line
Harvard psychologist: AI fear-mongering is the Y2K of the 21st century
UC San Diego researchers apply AI to diagnose eye diseases: 4 things to know